Abstract
Evolution to myelofibrosis (MF), acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) may occur over time in myeloproliferative neoplasms (MPN) patients most likely due to the acquisition of additional mutations. The Groupe Francophone de cytogenetique hematologique (GFCH) has collected and reviewed 82 patients with transformation of MPN (66 AML/MDS and 16 MF). JAK2V617F and TET2 mutations were searched for in 40 and 32 patients, respectively. Significantly more -7/del(7q) (P = 0.004) and -5/del(5q) (P = 0.03) were found in AML/MDS with a higher incidence of dup1q (P = 0.01) in MF. Some specific chromosomal abnormalities occurred together, for example -5/del(5q) and -17/del(17p) (P = 0.0007). In multivariate analysis, two factors were independently associated with an inferior overall survival (OS); AML/MDS transformation (P < 0.0001) and -5/del(5q) abnormality (P = 0.02). Although both giving rise to loss of 7q, der(1;7) differed from other 7q deletions in terms of distribution (lower frequency of AML/MDS, P = 0.02), association with chromosomal abnormalities (absence of -5/del(5q), P = 0.003; increased del(20q), P = 0.05), and longer OS (P = 0.0007). We detected 24/40 (60%) JAK2V617F and 8/25 (32%) TET2 mutations in sa...Continue Reading
References
Nov 1, 1994·British Journal of Haematology·J T ReillyA Potter
Mar 4, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·N L HarrisC D Bloomfield
May 31, 2001·British Journal of Haematology·A TefferiG W Dewald
Jun 21, 2003·Blood·Lili WangHisamaru Hirai
Sep 25, 2004·Blood·Ruben A MesaAyalew Tefferi
Dec 9, 2004·Blood·Guido FinazziUNKNOWN ECLAP Investigators
May 28, 2005·Leukemia·F ViguiéN Casadevall
Oct 18, 2005·British Journal of Haematology·Ayalew TefferiD Gary Gilliland
Jul 29, 2006·Blood·Peter J CampbellAnthony R Green
Dec 8, 2006·The New England Journal of Medicine·Peter J Campbell, Anthony R Green
Feb 23, 2007·Leukemia·M SanadaS Ogawa
Mar 27, 2007·Cancer Letters·Anna D Panani
Sep 21, 2007·Leukemia·A Tefferi, J W Vardiman
Jan 18, 2008·Leukemia·J Pedersen-BjergaardD H Christiansen
Aug 30, 2008·Leukemia·O Kilpivaara, R L Levine
Nov 8, 2008·Blood·Francisco CervantesAyalew Tefferi
Dec 2, 2008·Haematologica·Paola GuglielmelliAlessandro M Vannucchi
Jan 10, 2009·Blood·Constantine S TamSrdan Verstovsek
Mar 6, 2009·Leukemia·A TefferiR L Levine
May 6, 2009·Annals of Hematology·Ulrike BacherClaudia Haferlach
May 8, 2009·Blood·Omar Abdel-WahabRoss L Levine
May 29, 2009·The New England Journal of Medicine·François DelhommeauOlivier A Bernard
Aug 28, 2009·Leukemia·L CouronnéF Nguyen-Khac
Sep 11, 2009·The New England Journal of Medicine·Ayalew TefferiRoss Levine
Nov 11, 2009·Blood·Kebede HusseinAyalew Tefferi
Dec 17, 2009·Blood·Philip A BeerAnthony R Green
Citations
Dec 28, 2011·Current Hematologic Malignancy Reports·Elodie Pronier, François Delhommeau
Jan 1, 2011·Blood Cancer Journal·A TefferiT Mughal
Dec 18, 2013·Cancer Letters·Michael L O'ConnorWei Duan
Apr 11, 2013·Cancer Genetics·Gesa HauckKais Hussein
Jan 14, 2012·Biochimica Et Biophysica Acta·Thomas MercherOlivier A Bernard
Sep 29, 2011·American Journal of Hematology·Elisa RumiMario Cazzola
Jun 20, 2013·BioMed Research International·Andrea PatriarcaAlfredo Dragani
Dec 29, 2013·Leukemia Research Reports·Laura Laine HerborgAnne Stidsholt Roug
May 4, 2016·Annals of Laboratory Medicine·Jae Ryuk KimChan Jeoung Park